Oncolytic virotherapy is an official, innovative and effective cancer treatment using a special virus which is capable of finding and destroying cells of a malignant tumor in the human body. The medication is injected intramusculary. To learn more about virotherapy visit For Patients section or see here: www.virotherapy.com/about-therapy.
Virotherapy is received on an in-patient or out-patient basis, depending on the situation and a patient’s health condition. The therapy is conducted according to an individual treatment protocol and in accordance with the application guidelines under the supervision of the doctor. Average treatment period is 3 years during which a regular monitoring of test and patient's overall state of health takes place.
Cancer virotherapy is a treatment method that is gentle to the body and has minimum side effects. Most common side effect is slightly increased body temperature (up to 37.5°C, 99.5°F) lasting one to three days.
Oncolytic Virotherapy can be practiced only by doctors who have completed the educational course and are certified to apply this treatment and prescribe virotherapy medication. Training is organized by an independent company International Virotherapy Center in cooperation with the International Association of Virotherapy.
Oncolytic Virotherapy with ECHO-7 virus is available worldwide and is practiced by:
Virotherapy is practiced by:
If you wish to find out more about possibilities of virotherapy treatment in your particular case, to find the closest virotherapy delivery location, to learn more about the treatment process or other related issues, please, contact the patient information center email@example.com operated by independent International Virotherapy Center or visit For Patients section and find out if virotherapy can help you by filling the form. If Rigvir group receives any information from patients, we forward it to the independent Patient Information center of International Virotherapy Center.
Training is organized by an independent company International Virotherapy Center in cooperation with the International Association of Virotherapy.
If you wish to complete training course and recive certificate, please contact International Virotherapy Center by e-mail: firstname.lastname@example.org.
RIGVIR® should be stored at -20 °C and transported frozen.
International partner in transport organization: www.medserviceagency.com